ACTINIUM PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Deferred Tax Assets, Operating Loss Carryforwards of $62.55 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $62.55M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $47.88M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $41.70M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $44.23M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $62.55M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $47.88M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $41.70M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $44.23M 10-K · filed 2024-03-29 | |
| 2021-12-31 | $36.41M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $33.95M 10-K · filed 2022-03-25 | |
| 2019-12-31 | $31.69M 10-K · filed 2021-03-31 | $31.69M 10-K · filed 2020-05-08 |
| 2018-12-31 | $34.53M 10-K · filed 2020-05-08 | |
| 2017-12-31 | $30.83M 10-K · filed 2019-03-15 | |
| 2016-12-31 | $38.87M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $24.01M 10-K · filed 2017-03-16 | $28.91M 10-K · filed 2016-03-11 |
| 2014-12-31 | $22.87M 10-K · filed 2016-03-11 | |
| 2013-12-31 | $17.88M 10-K · filed 2015-03-16 | $14.80M 10-K · filed 2014-02-28 |
| 2012-12-31 | $14.08M 10-K · filed 2014-02-28 | $13.61M 10-K · filed 2013-03-29 |
| 2011-12-31 | $13.09M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |